150 related articles for article (PubMed ID: 1081933)
21. Characterization of mononuclear effector cells in human blood.
Hersey P; Edwards A; Edwards J
Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
[TBL] [Abstract][Full Text] [Related]
22. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
Pluzańska A
Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
[No Abstract] [Full Text] [Related]
23. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
Borowitz MJ; Croker BP; Metzgar RS
Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
25. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
26. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
27. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
28. [Effect of cytotoxic Hodgkin's serum on LIF activity of T- and B-lymphocytes].
Chisesi T; Giacobbo M; Capnist T
Boll Ist Sieroter Milan; 1978 Sep; 57(4):428-33. PubMed ID: 310684
[TBL] [Abstract][Full Text] [Related]
29. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
30. Effect of radiotherapy on lymphocyte cytotoxicity in vitro.
Wasserman J; Melén B; Blomgren H; Glas U; Perlmann P
Clin Exp Immunol; 1975 Nov; 22(2):230-9. PubMed ID: 1082400
[TBL] [Abstract][Full Text] [Related]
31. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
[TBL] [Abstract][Full Text] [Related]
32. Antibody-dependent cellular cytotoxic activity in patients with Hodgkin disease.
Láng I; Berényi E; Szegedi G; Török K; Fekete B; Gergely P
Acta Med Acad Sci Hung; 1977; 34(4):241-5. PubMed ID: 618055
[TBL] [Abstract][Full Text] [Related]
33. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
[TBL] [Abstract][Full Text] [Related]
34. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
35. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
36. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin's disease in children: investigation of T and B lymphocytes.
Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
[TBL] [Abstract][Full Text] [Related]
38. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
39. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
40. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
